BRUCE D GIVEN
CIK 1219384 · Chief Operating Officer · last filed 2020-04-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$70.09M
Companies
2
Total Filings
27
Lifetime Open-Market Net
-$14.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARWR | Chief Operating Officer | 854,788 | $82.00 | $70.09M | -$14.16M | 26 | 2020-04-29 |
| ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted | President & CEO | 298,174 | — | — | $0 | 1 | 2007-03-16 |
Recent Filings · Page 2 of 3
27 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-24 | ARWR | Sell (S) | −169,500 | -$2.30M | EDGAR |
| 2019-01-16 | ARWR | Mixed | −30,000 | -$577.6K | EDGAR |
| 2019-01-03 | ARWR | Mixed | +190,000 | -$239.6K | EDGAR |
| 2018-03-05 | ARWR | Sell (S) | −20,000 | -$134.6K | EDGAR |
| 2018-01-03 | ARWR | Mixed | +155,000 | -$73.8K | EDGAR |
| 2017-01-04 | ARWR | Grant (A) | +380,000 | $0 | EDGAR |
| 2016-03-08 | ARWR | Tax (F) | −13,675 | -$59.2K | EDGAR |
| 2016-02-09 | ARWR | Tax (F) | −17,969 | -$62.2K | EDGAR |
| 2016-01-04 | ARWR | Grant (A) | +150,000 | $0 | EDGAR |
| 2015-03-06 | ARWR | Grant (A) | +150,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.